(99m)Tc-labeled Rituximab for Imaging B Lymphocyte Infiltration in Inflammatory Autoimmune Disease Patients

PURPOSE: The rationale of the present study was to radiolabel rituximab with 99m-technetium and to image B lymphocytes infiltration in the affected tissues of patients with chronic inflammatory autoimmune diseases, in particular, the candidates to be treated with unlabelled rituximab, in order to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Malviya, G., Anzola, K. L., Podestà, E., Laganà, B., Del Mastro, C., Dierckx, R. A., Scopinaro, F., Signore, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443359/
https://www.ncbi.nlm.nih.gov/pubmed/22127469
http://dx.doi.org/10.1007/s11307-011-0527-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443359/
https://www.ncbi.nlm.nih.gov/pubmed/22127469
http://dx.doi.org/10.1007/s11307-011-0527-x

Ejemplares similares